{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:26Z","timestamp":1791925706141,"version":"4.3.4"},"reference-count":251,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bbalip.2022.159123","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T20:36:55Z","timestamp":1644525415000},"page":"159123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders"],"prefix":"10.1016","volume":"1867","author":[{"given":"Marta","family":"Turri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Adorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Zimetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2022.159123_bb0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/BC.2009.035","article-title":"Central nervous system: cholesterol turnover, brain development and neurodegeneration","volume":"390","author":"Dietschy","year":"2009","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1073858410373835","article-title":"Cholesterol: a novel regulatory role in myelin formation","volume":"17","author":"Saher","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbalip.2022.159123_bb0015","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.bjp.0704360","article-title":"Influence of membrane cholesterol on modulation of the GABA(A) receptor by neuroactive steroids and other potentiators","volume":"134","author":"Sooksawate","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0020","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","article-title":"Cholesterol homeostasis and function in neurons of the central nervous system","volume":"60","author":"Pfrieger","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsbmb.2018.12.009","article-title":"On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review)","volume":"188","author":"Bjorkhem","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.devbrainres.2003.09.015","article-title":"Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse","volume":"146","author":"Quan","year":"2003","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0035","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2022.159123_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2012.06.007","article-title":"Regulation of cholesterol homeostasis","volume":"368","author":"van der Wulp","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","article-title":"Cholesterol metabolism in neurons and astrocytes","volume":"50","author":"Pfrieger","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0050","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuropharm.2008.02.019","article-title":"Lipid rafts, cholesterol, and the brain","volume":"55","author":"Korade","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbalip.2022.159123_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2012.06.053","article-title":"Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases","volume":"64","author":"Sebastiao","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbalip.2022.159123_bb0060","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BST0340399","article-title":"Lipid dynamics in neurons","volume":"34","author":"Vance","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbalip.2022.159123_bb0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cvr\/cvu148","article-title":"HDL and cholesterol handling in the brain","volume":"103","author":"Vitali","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0070","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1073\/pnas.76.9.4646","article-title":"Apolipoproteins in human cerebrospinal fluid","volume":"76","author":"Roheim","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2022.159123_bb0075","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","article-title":"Characterization of four lipoprotein classes in human cerebrospinal fluid","volume":"42","author":"Koch","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0080","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain","volume":"262","author":"Pitas","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0085","first-page":"806","article-title":"Formation and function of apolipoprotein E-containing lipoproteins in the nervous system","volume":"2010","author":"Vance","year":"1801","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2022.159123_bb0090","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1046\/j.1471-4159.1998.70052070.x","article-title":"Nascent astrocyte particles differ from lipoproteins in CSF","volume":"70","author":"LaDu","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0095","doi-asserted-by":"crossref","first-page":"14208","DOI":"10.1074\/jbc.M114.625251","article-title":"Apolipoprotein E inhibits cerebrovascular pericyte mobility through a RhoA protein-mediated pathway","volume":"290","author":"Casey","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1749-6632.2000.tb06365.x","article-title":"Lipoproteins in the central nervous system","volume":"903","author":"Ladu","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-09665-0_1","article-title":"Structure of HDL: particle subclasses and molecular components","volume":"224","author":"Kontush","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(01)02263-7","article-title":"The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?","volume":"314","author":"Koudinov","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2022.159123_bb0115","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1006\/bbrc.1996.0940","article-title":"Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins","volume":"223","author":"Koudinov","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2022.159123_bb0120","article-title":"The HDL proteome watch: compilation of studies leads to new insights on HDL function","volume":"1867","author":"Davidson","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbalip.2022.159123_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","article-title":"Dynamics of brain-derived proteins in cerebrospinal fluid","volume":"310","author":"Reiber","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbalip.2022.159123_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206478","article-title":"Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research","volume":"13","author":"Schilde","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2022.159123_bb0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/epr.12.6","article-title":"The proteomic toolbox for studying cerebrospinal fluid","volume":"9","author":"van Gool","year":"2012","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.bbalip.2022.159123_bb0140","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-2275(20)32039-3","article-title":"Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease","volume":"41","author":"Demeester","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation","volume":"88","author":"Linton","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159123_bb0150","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.STR.0000064320.73388.C6","article-title":"Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction","volume":"34","author":"Aoki","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.bbalip.2022.159123_bb0155","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/nbdi.1999.0251","article-title":"Apolipoprotein E expression by neurons surviving excitotoxic stress","volume":"6","author":"Boschert","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/clp.10.37","article-title":"Apolipoproteins in the brain: implications for neurological and psychiatric disorders","volume":"51","author":"Elliott","year":"2010","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1124\/jpet.118.254201","article-title":"Apolipoprotein A-I crosses the blood-brain barrier through clathrin-independent and cholesterol-mediated endocytosis","volume":"369","author":"Zhou","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbalip.2022.159123_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(98)00639-9","article-title":"Pattern of apolipoprotein D immunoreactivity in human brain","volume":"254","author":"Navarro","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2022.159123_bb0175","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.neurobiolaging.2014.01.148","article-title":"Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain","volume":"35","author":"Dassati","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbalip.2022.159123_bb0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0197-0186(01)00049-3","article-title":"Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice","volume":"39","author":"DeMattos","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbalip.2022.159123_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11306-016-1023-8","article-title":"Annotation of the human cerebrospinal fluid lipidome using high resolution mass spectrometry and a dedicated data processing workflow","volume":"12","author":"Seyer","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.bbalip.2022.159123_bb0190","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1039\/D0MO00186D","article-title":"Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease","volume":"17","author":"Byeon","year":"2021","journal-title":"Mol. Omics"},{"key":"10.1016\/j.bbalip.2022.159123_bb0195","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1471-4159.1971.tb12006.x","article-title":"The composition of lipids in cerebrospinal fluid of children and adults","volume":"18","author":"Illingworth","year":"1971","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0200","first-page":"259","article-title":"Phospholipids in human cerebrospinal fluid","volume":"203","author":"Kunz","year":"1972","journal-title":"Z. Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0205","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1006\/bbrc.1994.2788","article-title":"The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma","volume":"205","author":"Koudinov","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2022.159123_bb0210","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1750-3639.2004.tb00088.x","article-title":"Apolipoprotein abeta: black sheep in a good family","volume":"14","author":"Kontush","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/cbir.1996.0126","article-title":"Alzheimer's soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein","volume":"21","author":"Koudinov","year":"1997","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbalip.2022.159123_bb0220","article-title":"Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-beta","volume":"1866","author":"Chai","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbalip.2022.159123_bb0225","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","article-title":"Cerebrovascular effects of apolipoprotein E: implications for alzheimer disease","volume":"70","author":"Zlokovic","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0230","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tem.2013.10.003","article-title":"What are lipoproteins doing in the brain?","volume":"25","author":"Wang","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2022.159123_bb0240","doi-asserted-by":"crossref","first-page":"41197","DOI":"10.1074\/jbc.M407962200","article-title":"Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain","volume":"279","author":"Hirsch-Reinshagen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.04.037","article-title":"Astrocytes endogenous apoE generates HDL-like lipoproteins using previously synthesized cholesterol through interaction with ABCA1","volume":"1570","author":"Ito","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0250","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1471-4159.2007.05099.x","article-title":"Role of ATP-binding cassette transporters in brain lipid transport and neurological disease","volume":"104","author":"Kim","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0255","first-page":"573","article-title":"Implications of cerebrovascular ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein M in cholesterol transport at the blood-brain barrier","volume":"2017","author":"Kober","year":"1862","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbalip.2022.159123_bb0260","first-page":"658","article-title":"Lysophosphatidylcholine export by human ABCA7","volume":"2017","author":"Tomioka","year":"1862","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbalip.2022.159123_bb0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1388-1981(00)00153-0","article-title":"Lecithin cholesterol acyltransferase","volume":"1529","author":"Jonas","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2022.159123_bb0270","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1194\/jlr.M800584-JLR200","article-title":"LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins","volume":"50","author":"Hirsch-Reinshagen","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0275","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF02591657","article-title":"Cholesteryl ester transfer protein in human brain","volume":"21","author":"Albers","year":"1992","journal-title":"Int. J. Clin. Lab. Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0280","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1074\/jbc.M113.499129","article-title":"Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrier","volume":"289","author":"Chirackal Manavalan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0285","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.1074\/jbc.271.14.8373","article-title":"Human apolipoprotein E receptor 2A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain","volume":"271","author":"Kim","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0290","doi-asserted-by":"crossref","first-page":"25754","DOI":"10.1074\/jbc.M502143200","article-title":"The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice","volume":"280","author":"Fryer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0295","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2007.08.008","article-title":"Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1","volume":"56","author":"Liu","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.bbalip.2022.159123_bb0300","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0305","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fncel.2016.00122","article-title":"New insights into reelin-mediated signaling pathways","volume":"10","author":"Lee","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0310","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0315","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2022.159123_bb0320","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M200293-JLR200","article-title":"On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function","volume":"43","author":"Meaney","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0325","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","article-title":"Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain","volume":"260","author":"Bjorkhem","year":"2006","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbalip.2022.159123_bb0330","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11883-021-00906-7","article-title":"APOA1: a protein with multiple therapeutic functions","volume":"23","author":"Cochran","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.bbalip.2022.159123_bb0335","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","article-title":"Plasma lipoproteins: apolipoprotein structure and function","volume":"25","author":"Mahley","year":"1984","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0340","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1046\/j.1471-4159.1996.66062429.x","article-title":"Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease","volume":"66","author":"Harr","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0345","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2014.01.003","article-title":"High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease","volume":"19","author":"Stukas","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2022.159123_bb0350","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3389\/fphys.2017.00841","article-title":"SR-BI mediated transcytosis of HDL in brain microvascular endothelial cells is independent of caveolin, clathrin, and PDZK1","volume":"8","author":"Fung","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0355","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/1873-3468.13950","article-title":"Apolipoprotein A-I in mouse cerebrospinal fluid derives from the liver and intestine via plasma high-density lipoproteins assembled by ABCA1 and LCAT","volume":"595","author":"Tsujita","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2022.159123_bb0360","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1523\/JNEUROSCI.4741-08.2009","article-title":"Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function","volume":"29","author":"Karasinska","year":"2009","journal-title":"the journal of neuroscience : the official journal of the society forNeuroscience"},{"key":"10.1016\/j.bbalip.2022.159123_bb0365","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/biof.1541","article-title":"Emerging roles for high-density lipoproteins in neurodegenerative disorders","volume":"45","author":"Bahrami","year":"2019","journal-title":"Biofactors"},{"key":"10.1016\/j.bbalip.2022.159123_bb0370","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/mp300518e","article-title":"Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules","volume":"10","author":"Strazielle","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbalip.2022.159123_bb0375","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001156","article-title":"Intravenously injected human apolipoprotein A-I rapidly enters the central nervous system via the choroid plexus","volume":"3","author":"Stukas","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbalip.2022.159123_bb0380","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fnins.2019.00419","article-title":"The extent of human apolipoprotein A-I lipidation strongly affects the beta-amyloid efflux across the blood-brain barrier in vitro","volume":"13","author":"Dal Magro","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0385","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1021\/bi002186k","article-title":"Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits abeta aggregation and toxicity","volume":"40","author":"Koldamova","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2022.159123_bb0390","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.biocel.2008.12.003","article-title":"Human apolipoprotein A-I binds amyloid-beta and prevents abeta-induced neurotoxicity","volume":"41","author":"Paula-Lima","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0395","first-page":"1027","article-title":"Reconstituted high-density lipoproteins acutely reduce soluble brain abeta levels in symptomatic APP\/PS1 mice","volume":"2016","author":"Robert","year":"1862","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2022.159123_bb0400","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/ATVBAHA.112.300921","article-title":"Apolipoprotein A-II: still second fiddle in high-density lipoprotein Metabolism?","volume":"33","author":"Remaley","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0405","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1373\/clinchem.2006.069294","article-title":"Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling","volume":"52","author":"de Bont","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0410","doi-asserted-by":"crossref","first-page":"R1382","DOI":"10.1152\/ajpregu.2001.280.5.R1382","article-title":"Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus","volume":"280","author":"Liu","year":"2001","journal-title":"american journal of physiologyRegulatory, integrative and comparative physiology"},{"key":"10.1016\/j.bbalip.2022.159123_bb0415","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1172\/JCI116395","article-title":"Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats","volume":"91","author":"Fujimoto","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159123_bb0420","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.physbeh.2008.05.022","article-title":"Characterization of apolipoprotein A-IV in brain areas involved in energy homeostasis","volume":"95","author":"Shen","year":"2008","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbalip.2022.159123_bb0425","article-title":"Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease","volume":"62","author":"Hu","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0430","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1194\/jlr.E015701","article-title":"Complexities of plasma apolipoprotein C-III metabolism","volume":"52","author":"Board","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235939","article-title":"Apolipoprotein C1: its pleiotropic effects in lipid metabolism and beyond","volume":"20","author":"Fuior","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0440","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2017.10.025","article-title":"Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism","volume":"267","author":"Wolska","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2022.159123_bb0445","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF00283370","article-title":"Localization of genes encoding apolipoproteins CI, CII, and E to the p13\u2013\u2013cen region of human chromosome 19","volume":"71","author":"Scott","year":"1985","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbalip.2022.159123_bb0450","article-title":"Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2022.159123_bb0455","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10238-007-0142-y","article-title":"ApoE epsilon2\/epsilon3\/epsilon4 polymorphism, ApoC-III\/ApoE ratio and metabolic syndrome","volume":"7","author":"Olivieri","year":"2007","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bbalip.2022.159123_bb0460","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1016\/S0021-9258(18)68638-7","article-title":"Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene","volume":"263","author":"Lauer","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0465","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12603-012-0018-z","article-title":"Serum high-density lipoprotein cholesterol levels correlate well with functional but not with cognitive status in 85-year-old subjects","volume":"16","author":"Formiga","year":"2012","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.bbalip.2022.159123_bb0470","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ana.20289","article-title":"Serum lipids and hippocampal volume: the link to Alzheimer's disease?","volume":"56","author":"Wolf","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0475","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/gerona\/glq026","article-title":"Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study","volume":"65","author":"Zuliani","year":"2010","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0480","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/00207454.2016.1182527","article-title":"Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women","volume":"127","author":"Bates","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0485","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1017\/S1355617714000885","article-title":"Higher HDL cholesterol is associated with better cognitive function: the Maine-Syracuse study","volume":"20","author":"Crichton","year":"2014","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.bbalip.2022.159123_bb0490","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fnagi.2020.00223","article-title":"Blood-based biomarkers for predictive diagnosis of cognitive impairment in a Pakistani population","volume":"12","author":"Iqbal","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0495","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2018.10.024","article-title":"Predictors of neurodegeneration differ between cognitively normal and subsequently impaired older adults","volume":"75","author":"Armstrong","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbalip.2022.159123_bb0500","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2174\/156720510792231694","article-title":"Low levels of high density lipoprotein increase the severity of cerebral white matter changes: implications for prevention and treatment of cerebrovascular diseases","volume":"7","author":"Crisby","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamaneurol.2013.5390","article-title":"Associations between serum cholesterol levels and cerebral amyloidosis","volume":"71","author":"Reed","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0510","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fnagi.2019.00370","article-title":"Revealing a novel landscape of the association between blood lipid levels and Alzheimer's disease: a meta-analysis of a case-control study","volume":"11","author":"Tang","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0515","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0197-4580(99)00103-7","article-title":"Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease","volume":"21","author":"Merched","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbalip.2022.159123_bb0520","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archneurol.2010.297","article-title":"Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset alzheimer disease","volume":"67","author":"Reitz","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0525","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neulet.2013.06.063","article-title":"Brain cortical thickness in the general elderly population: the Rotterdam scan study","volume":"550","author":"van Velsen","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2022.159123_bb0530","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/WNL.57.8.1447","article-title":"Cholesterol and neuropathologic markers of AD: a population-based autopsy study","volume":"57","author":"Launer","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbalip.2022.159123_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002265","article-title":"Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C study: a longitudinal, population-based prospective cohort study","volume":"14","author":"Schilling","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbalip.2022.159123_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/biom10091276","article-title":"The role of HDL and HDL mimetic peptides as potential therapeutics for Alzheimer's disease","volume":"10","author":"Chernick","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbalip.2022.159123_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8120542","article-title":"An increased plasma level of ApoCIII-rich electronegative high-density lipoprotein may contribute to cognitive impairment in Alzheimer's disease","volume":"8","author":"Chan","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbalip.2022.159123_bb0550","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1139\/cjpp-2016-0710","article-title":"Alteration of high-density lipoprotein functionality in Alzheimer's disease patients","volume":"95","author":"Camponova","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0555","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mad.2011.11.008","article-title":"Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease","volume":"133","author":"Khalil","year":"2012","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbalip.2022.159123_bb0560","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.116.305485","article-title":"HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export","volume":"116","author":"Du","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0565","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3233\/JAD-200291","article-title":"Plasma high density lipoprotein small subclass is reduced in Alzheimer's disease patients and correlates with cognitive performance","volume":"77","author":"Pedrini","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0570","doi-asserted-by":"crossref","first-page":"6695796","DOI":"10.1155\/2021\/6695796","article-title":"Connection between the altered HDL antioxidant and anti-inflammatory properties and the risk to develop Alzheimer's disease: a narrative review","volume":"2021","author":"Zimetti","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbalip.2022.159123_bb0575","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jalz.2015.04.006","article-title":"Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease","volume":"11","author":"Nordestgaard","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbalip.2022.159123_bb0580","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.conb.2019.11.024","article-title":"Genetics of Alzheimer's disease: where we are, and where we are going","volume":"61","author":"Bellenguez","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0585","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M504513200","article-title":"Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice","volume":"280","author":"Koldamova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0590","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","article-title":"ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE","volume":"279","author":"Wahrle","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0595","first-page":"671","article-title":"Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease","volume":"118","author":"Wahrle","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159123_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045959","article-title":"Role of Abca7 in mouse behaviours relevant to neurodegenerative diseases","volume":"7","author":"Logge","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2022.159123_bb0605","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1523\/JNEUROSCI.3757-15.2016","article-title":"ABCA7 deficiency accelerates amyloid-beta generation and Alzheimer's neuronal pathology","volume":"36","author":"Sakae","year":"2016","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.bbalip.2022.159123_bb0610","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-019-01994-1","article-title":"The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics","volume":"138","author":"De Roeck","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0615","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3233\/JAD-170883","article-title":"ABCA7 downregulation modifies cellular cholesterol homeostasis and decreases amyloid-beta peptide efflux in an in vitro model of the blood-brain barrier","volume":"64","author":"Lamartiniere","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0620","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1074\/jbc.M601019200","article-title":"24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux","volume":"281","author":"Abildayeva","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0625","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10048-007-0087-z","article-title":"Association study of cholesterol-related genes in Alzheimer's disease","volume":"8","author":"Wollmer","year":"2007","journal-title":"Neurogenetics"},{"key":"10.1016\/j.bbalip.2022.159123_bb0630","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1194\/jlr.M700481-JLR200","article-title":"ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo","volume":"49","author":"Burgess","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0635","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1074\/jbc.M607831200","article-title":"Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation","volume":"282","author":"Kim","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155400","article-title":"ABCG1 and ABCG4 suppress gamma-secretase activity and amyloid beta production","volume":"11","author":"Sano","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2022.159123_bb0645","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1194\/jlr.M600542-JLR200","article-title":"The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of beta-amyloid precursor protein","volume":"48","author":"Tansley","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0650","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jnen\/nlw067","article-title":"Apolipoprotein E genotype affects size of ApoE complexes in cerebrospinal fluid","volume":"75","author":"Heinsinger","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0655","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","article-title":"APOE epsilon4\/epsilon4 diminishes neurotrophic function of human iPSC-derived astrocytes","volume":"26","author":"Zhao","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2022.159123_bb0660","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","article-title":"Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture","volume":"74","author":"Michikawa","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0665","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/jnr.22073","article-title":"Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture","volume":"87","author":"Minagawa","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0670","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1523\/JNEUROSCI.1400-19.2019","article-title":"ApoE4 alters ABCA1 membrane trafficking in astrocytes","volume":"39","author":"Rawat","year":"2019","journal-title":"the journal of neuroscience : the official journal of the society forNeuroscience39"},{"issue":"Pt 2","key":"10.1016\/j.bbalip.2022.159123_bb0675","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/bj3480359","article-title":"Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides","volume":"348","author":"Tokuda","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2022.159123_bb0680","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbalip.2022.159123_bb0685","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jns.2015.12.004","article-title":"Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"360","author":"Talwar","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0690","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-020-00585-7","article-title":"Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases","volume":"12","author":"Minta","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbalip.2022.159123_bb0695","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/1097-0029(20000815)50:4<282::AID-JEMT6>3.0.CO;2-T","article-title":"Cerebrospinal fluid lipoproteins in Alzheimer's disease","volume":"50","author":"Bassett","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.bbalip.2022.159123_bb0700","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s11745-999-0478-1","article-title":"Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo","volume":"34","author":"Bassett","year":"1999","journal-title":"Lipids"},{"key":"10.1016\/j.bbalip.2022.159123_bb0705","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1196\/annals.1331.025","article-title":"Vitamin E in neurodegenerative disorders: Alzheimer's disease","volume":"1031","author":"Kontush","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0710","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0891-5849(99)00247-6","article-title":"Increased lipoprotein oxidation in Alzheimer's disease","volume":"28","author":"Schippling","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbalip.2022.159123_bb0715","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2022.159123_bb0720","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12944-016-0288-2","article-title":"APOE genotype and stress response - a mini review","volume":"15","author":"Dose","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0725","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3233\/JAD-150738","article-title":"Apolipoprotein E4 elicits lysosomal cathepsin D release, decreased Thioredoxin-1 levels, and apoptosis","volume":"56","author":"Persson","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0730","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbalip.2022.159123_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104795","article-title":"Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease","volume":"138","author":"Butterfield","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0740","article-title":"HDL proteome and Alzheimer's disease: evidence of a link","volume":"9","author":"Marsillach","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bbalip.2022.159123_bb0745","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1179\/016164106X98035","article-title":"Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects","volume":"28","author":"Castano","year":"2006","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0750","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179280","article-title":"Protein signature in cerebrospinal fluid and serum of Alzheimer's disease patients: the case of apolipoprotein A-1 proteoforms","volume":"12","author":"Fania","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2022.159123_bb0755","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-170226","article-title":"Reduced cerebrospinal fluid concentration of apolipoprotein A-I in patients with Alzheimer's disease","volume":"59","author":"Johansson","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0760","doi-asserted-by":"crossref","first-page":"36958","DOI":"10.1074\/jbc.M110.127829","article-title":"Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of alzheimer disease","volume":"285","author":"Lewis","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0765","doi-asserted-by":"crossref","first-page":"36945","DOI":"10.1074\/jbc.M110.127738","article-title":"Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP\/PS1DeltaE9 mice","volume":"285","author":"Lefterov","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0770","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1194\/jlr.P091033","article-title":"ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease","volume":"60","author":"Marchi","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0775","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3233\/JAD-151068","article-title":"Apolipoprotein A1 in cerebrospinal fluid and plasma and progression to Alzheimer's disease in non-demented elderly","volume":"56","author":"Slot","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0780","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/ADR-190165","article-title":"Apolipoprotein A1 in cerebrospinal fluid is insufficient to distinguish Alzheimer's disease from other dementias in a naturalistic, clinical setting","volume":"4","author":"Stoye","year":"2020","journal-title":"J. Alzheimers. Dis. Rep."},{"key":"10.1016\/j.bbalip.2022.159123_bb0785","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11011-018-0325-0","article-title":"Association between clusterin concentration and dementia: a systematic review and meta-analysis","volume":"34","author":"Yang","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0790","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002886","article-title":"ABCA1-mediated cholesterol efflux capacity to cerebrospinal fluid is reduced in patients with mild cognitive impairment and Alzheimer's disease","volume":"5","author":"Yassine","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbalip.2022.159123_bb0795","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030574","article-title":"High density lipoprotein cholesterol efflux capacity and atherosclerosis in cardiovascular disease: pathophysiological aspects and pharmacological perspectives","volume":"10","author":"Adorni","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbalip.2022.159123_bb0800","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3233\/JAD-160930","article-title":"The level of 24-hydroxycholesteryl esters is an early marker of Alzheimer's disease","volume":"56","author":"Benussi","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0805","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1194\/jlr.M049940","article-title":"LCAT deficiency does not impair amyloid metabolism in APP\/PS1 mice","volume":"55","author":"Stukas","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0810","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1194\/jlr.M300046-JLR200","article-title":"Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease","volume":"44","author":"Vuletic","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0815","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jnr.20458","article-title":"Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro","volume":"80","author":"Vuletic","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0820","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/npp.2012.247","article-title":"Increased amyloid-beta peptide-induced memory deficits in phospholipid transfer protein (PLTP) gene knockout mice","volume":"38","author":"Desrumaux","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbalip.2022.159123_bb0825","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1093\/hmg\/ddv262","article-title":"Phospholipid transfer protein (PLTP) deficiency accelerates memory dysfunction through altering amyloid precursor protein (APP) processing in a mouse model of Alzheimer's disease","volume":"24","author":"Tong","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2022.159123_bb0830","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/JAD-130812","article-title":"PLTP deficiency impairs learning and memory capabilities partially due to alteration of amyloid-beta metabolism in old mice","volume":"39","author":"Wang","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0835","doi-asserted-by":"crossref","first-page":"19688","DOI":"10.18632\/oncotarget.24802","article-title":"Deletion of plasma phospholipid transfer protein (PLTP) increases microglial phagocytosis and reduces cerebral amyloid-beta deposition in the J20 mouse model of Alzheimer's disease","volume":"9","author":"Mansuy","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbalip.2022.159123_bb0840","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1021\/acs.biochem.5b00681","article-title":"Influence of isoforms and carboxyl-terminal truncations on the capacity of apolipoprotein E to associate with and activate phospholipid transfer protein","volume":"54","author":"Dafnis","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2022.159123_bb0845","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/jama.2009.1988","article-title":"Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2022.159123_bb0850","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/dna.2013.2265","article-title":"Relationships between CETP genetic polymorphisms and Alzheimer's disease risk: a meta-analysis","volume":"33","author":"Chen","year":"2014","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2008.07.047","article-title":"CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk","volume":"1232","author":"Qureischie","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb0860","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11682-011-9137-0","article-title":"Alzheimer's disease neuroimaging, CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner","volume":"6","author":"Murphy","year":"2012","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.bbalip.2022.159123_bb0865","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neurobiolaging.2016.02.006","article-title":"Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein epsilon4 on memory decline in older adults","volume":"41","author":"Sundermann","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbalip.2022.159123_bb0870","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ng1095-207","article-title":"Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease","volume":"11","author":"Okuizumi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2022.159123_bb0875","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0304-3940(02)00942-4","article-title":"Low-density lipoprotein receptor-related protein 8 (apolipoprotein E receptor 2) gene polymorphisms in Alzheimer's disease","volume":"332","author":"Ma","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2022.159123_bb0880","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1672","article-title":"Alzheimer's amyloid-beta and tau protein accumulation is associated with decreased expression of the LDL receptor-associated protein in human brain tissue","volume":"10","author":"Shepherd","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.bbalip.2022.159123_bb0885","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-190742","article-title":"LDL receptor deficiency does not Alter brain amyloid-beta levels but causes an exacerbation of apoptosis","volume":"73","author":"de Oliveira","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0890","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1172\/JCI124853","article-title":"APOE4-mediated amyloid-beta pathology depends on its neuronal receptor LRP1","volume":"129","author":"Tachibana","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159123_bb0895","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.630502","article-title":"APOE and Alzheimer's disease: from lipid transport to physiopathology and therapeutics","volume":"15","author":"Husain","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0900","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","article-title":"Apolipoprotein E, receptors, and modulation of Alzheimer's disease","volume":"83","author":"Zhao","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbalip.2022.159123_bb0905","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fnagi.2015.00136","article-title":"Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1","volume":"7","author":"Ramanathan","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb0910","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of abeta isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbalip.2022.159123_bb0915","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta-peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2022.159123_bb0920","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","article-title":"Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-beta42 by LRP1-dependent apolipoprotein E isoform-specific mechanism","volume":"13","author":"Ma","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbalip.2022.159123_bb0925","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1007\/s12035-020-01982-7","article-title":"Silencing of LRP1 exacerbates inflammatory response via TLR4\/NF-kappaB\/MAPKs signaling pathways in APP\/PS1 transgenic mice","volume":"57","author":"He","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0930","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-beta(1\u201342) across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159123_bb0935","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbalip.2022.159123_bb0940","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1093\/eurheartj\/suaa063","article-title":"Proprotein convertase subtilisin\/kexin type 9: an update on the cardiovascular outcome studies","volume":"22","author":"Ferri","year":"2020","journal-title":"Eur. Heart J. Suppl"},{"key":"10.1016\/j.bbalip.2022.159123_bb0945","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fnagi.2019.00120","article-title":"Proprotein convertase subtilisin\/kexin type 9, brain cholesterol homeostasis and potential implication for Alzheimer's disease","volume":"11","author":"Adorni","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bbalip.2022.159123_bb0950","article-title":"The blood-brain barrier in Alzheimer\u2019s disease","author":"Storck","year":"2021","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0955","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3233\/JAD-170993","article-title":"PCSK9 concentrations in cerebrospinal fluid are not specifically increased in Alzheimer's disease","volume":"62","author":"Courtemanche","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0960","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/JAD-160411","article-title":"Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer's disease","volume":"55","author":"Zimetti","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb0965","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220254","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study","volume":"14","author":"Picard","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2022.159123_bb0970","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2022.159123_bb0975","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0891988718764330","article-title":"Loss-of-function PCSK9 mutations are not associated with alzheimer disease","volume":"31","author":"Paquette","year":"2018","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0980","article-title":"Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: mendelian randomisation study","volume":"357","author":"Benn","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.bbalip.2022.159123_bb0985","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb0990","doi-asserted-by":"crossref","first-page":"34834","DOI":"10.1038\/srep34834","article-title":"Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhage","volume":"6","author":"Lei","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2022.159123_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146685","article-title":"ApoE mimetic improves pathology and memory in a model of Alzheimer's disease","volume":"1733","author":"Krishnamurthy","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb1000","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fnins.2018.00127","article-title":"Apolipoprotein E-mimetic peptide COG1410 promotes autophagy by phosphorylating GSK-3beta in early brain injury following experimental subarachnoid hemorrhage","volume":"12","author":"Li","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb1005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000334914","article-title":"APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer's disease transgenics","volume":"10","author":"Vitek","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb1010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.expneurol.2017.10.014","article-title":"Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury","volume":"299","author":"Cheng","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb1015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000341299","article-title":"The apolipoprotein-E-mimetic COG112 protects amyloid precursor protein intracellular domain-overexpressing animals from Alzheimer's disease-like pathological features","volume":"12","author":"Ghosal","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb1020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","article-title":"Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and abeta metabolism in apoE4-targeted replacement mice","volume":"10","author":"Hu","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"Pt A","key":"10.1016\/j.bbalip.2022.159123_bb1025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2014.05.007","article-title":"ATP-binding cassette transporter A1: from metabolism to neurodegeneration","volume":"72","author":"Koldamova","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb1030","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2022.159123_bb1035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.trci.2016.06.001","article-title":"A randomized controlled study to evaluate the effect of bexarotene on amyloid-beta and apolipoprotein E metabolism in healthy subjects","volume":"2","author":"Ghosal","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.bbalip.2022.159123_bb1040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13195-016-0173-2","article-title":"Double-blind, placebo-controlled, proof-of-concept trial of bexarotene xin moderate Alzheimer's disease","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimers Res. Ther."},{"issue":"Suppl 2","key":"10.1016\/j.bbalip.2022.159123_bb1045","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.neurobiolaging.2014.03.037","article-title":"Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease","volume":"35","author":"Poirier","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbalip.2022.159123_bb1050","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI96429","article-title":"Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation","volume":"128","author":"Liao","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2022.159123_bb1055","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1074\/jbc.M114.622209","article-title":"Role of apolipoprotein E in beta-amyloidogenesis: ISOFORM-SPECIFIC EFFECTS ON PROTOFIBRIL TO FIBRIL CONVERSION OF abeta IN VITRO AND BRAIN abeta DEPOSITION IN VIVO","volume":"290","author":"Hori","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2022.159123_bb1060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2022.159123_bb1065","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20171265","article-title":"ApoE facilitates the microglial response to amyloid plaque pathology","volume":"215","author":"Ulrich","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbalip.2022.159123_bb1070","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuron.2009.11.013","article-title":"Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular a beta clearance","volume":"64","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.bbalip.2022.159123_bb1075","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1206446109","article-title":"Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood abeta clearance in a mouse model of beta-amyloidosis","volume":"109","author":"Castellano","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2022.159123_bb1080","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of beta-amyloidosis","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.bbalip.2022.159123_bb1085","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer's disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.bbalip.2022.159123_bb1090","doi-asserted-by":"crossref","first-page":"212ra161","DOI":"10.1126\/scitranslmed.3007000","article-title":"Gene transfer of human apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain","volume":"5","author":"Hudry","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbalip.2022.159123_bb1095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neurobiolaging.2017.08.028","article-title":"Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease","volume":"60","author":"Fernandez-de Retana","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbalip.2022.159123_bb1100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.120.265876","article-title":"High-density lipoprotein mimetic peptide 4F efficiently crosses the blood-brain barrier and modulates amyloid-beta distribution between brain and plasma","volume":"375","author":"Swaminathan","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbalip.2022.159123_bb1105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.nbd.2009.03.007","article-title":"Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease","volume":"34","author":"Handattu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb1110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson's disease and parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbalip.2022.159123_bb1115","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2022.159123_bb1120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12944-020-01284-w","article-title":"A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson's disease","volume":"19","author":"Fu","year":"2020","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb1125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCRESAHA.119.314929","article-title":"Lipids, apolipoproteins, and the risk of parkinson disease","volume":"125","author":"Fang","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2022.159123_bb1130","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.nut.2013.04.013","article-title":"Cardiometabolic factors and disease duration in patients with Parkinson's disease","volume":"29","author":"Cassani","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.bbalip.2022.159123_bb1135","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/psyg.12483","article-title":"Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease","volume":"20","author":"Li","year":"2020","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.bbalip.2022.159123_bb1140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/1873-3468.12543","article-title":"High-density lipoprotein-like particle formation of synuclein variants","volume":"591","author":"Eichmann","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2022.159123_bb1145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.23872","article-title":"Plasma apolipoprotein A1 as a biomarker for Parkinson disease","volume":"74","author":"Qiang","year":"2013","journal-title":"Annals of neurology"},{"key":"10.1016\/j.bbalip.2022.159123_bb1150","first-page":"350","article-title":"Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson's disease","volume":"122","author":"Wang","year":"2010","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.bbalip.2022.159123_bb1155","first-page":"66","article-title":"Association of Paraoxonse1 (PON1) genotypes with the activity of PON1 in patients with Parkinson's disease","volume":"28","author":"Mota","year":"2019","journal-title":"Acta Neurol. Taiwanica"},{"key":"10.1016\/j.bbalip.2022.159123_bb1160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2012.06.007","article-title":"Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease","volume":"522","author":"Belin","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2022.159123_bb1165","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jocn.2011.01.028","article-title":"Association between apolipoprotein E genotypes and Parkinson's disease","volume":"18","author":"Pulkes","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb1170","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1212\/01.WNL.0000130159.28215.6A","article-title":"APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease","volume":"62","author":"Huang","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbalip.2022.159123_bb1175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0891988709332945","article-title":"APOE alleles in parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study","volume":"22","author":"Kurz","year":"2009","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb1180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neulet.2006.07.080","article-title":"Association of APOE with parkinson disease age-at-onset in women","volume":"411","author":"Buchanan","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2022.159123_bb1185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE epsilon4 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbalip.2022.159123_bb1190","doi-asserted-by":"crossref","first-page":"15226","DOI":"10.1073\/pnas.1821409116","article-title":"Alpha-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients","volume":"116","author":"Paslawski","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2022.159123_bb1195","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.nbd.2003.10.003","article-title":"Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication","volume":"15","author":"Buhmann","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb1200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2022.159123_bb1205","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbalip.2022.159123_bb1210","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","article-title":"Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes","volume":"30","author":"Valenza","year":"2010","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.bbalip.2022.159123_bb1215","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease","volume":"25","author":"Valenza","year":"2005","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.bbalip.2022.159123_bb1220","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/cdd.2014.162","article-title":"Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease","volume":"22","author":"Valenza","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbalip.2022.159123_bb1225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2013.03.013","article-title":"P.-h.S. Group, plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression","volume":"55","author":"Leoni","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb1230","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","article-title":"Frontotemporal dementia","volume":"386","author":"Bang","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2022.159123_bb1235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1745017901309010088","article-title":"Epidemiology of early-onset dementia: a review of the literature","volume":"9","author":"Vieira","year":"2013","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.bbalip.2022.159123_bb1240","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbalip.2022.159123_bb1245","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fnins.2018.00847","article-title":"Altered high density lipoprotein composition in behavioral variant frontotemporal dementia","volume":"12","author":"Kim","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbalip.2022.159123_bb1250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-190132","article-title":"Low serum high-density lipoprotein cholesterol levels associate with the C9orf72 repeat expansion in frontotemporal lobar degeneration patients","volume":"72","author":"Jaaskelainen","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2022.159123_bb1255","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1212\/WNL.0000000000000993","article-title":"Systemic metabolism in frontotemporal dementia","volume":"83","author":"Ahmed","year":"2014","journal-title":"Neurology"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198122000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198122000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:12:50Z","timestamp":1761387170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198122000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":251,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1388198122000130"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2022.159123","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2022.159123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"159123"}}